Clinical Trial Update: Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports completed Phase 1 and Phase 2 results for flavopiridol in previously treated chronic lymphocytic leukemia and lymphocytic lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• Flavopiridol (alvocidib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: B-cell Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-02